Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07683624

Effect of Biofeedback-Based Inertial Sensors Gait Training on Walking Parameters in Children With Hemiplegia

Conditions: Hemiplegic Cerebral Palsy, Gait Training

Sex: All
Ages: 7 Years – 12 Years
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Cairo University

Location: Faculty of Physical Therapy Cairo University Cairo

Summary

The goal of this clinical trial is to learn about the effect of biofeedback-based inertial sensors gait training on walking parameters in children with hemiplegia. The main question it aims to answer is: Does biofeedback-based inertial sensors gait training have an effect on walking parameters in children with hemiplegia. * Participants in the study and control groups will receive 30 minutes designed physical therapy program, three times per week for three successive months. * Children in the control group will receive traditional gait training for 30 minutes, three times per week for three successive months. * Children in the study group will receive 30 minutes biofeedback-based inertial sensors gait training session three times per week for three successive months.

Eligibility Criteria

Inclusion Criteria: * Their age will range from 7 to 12 years. * The degree of their spasticity will range from 1 to 1+ according to Modified Ashworth' Scale (Bohannon et al., 1987) (Appendix IⅠ). * They will be on level Ⅰ or Ⅱ on GMFCS (Palisano et al., 2007) (Appendix IⅡ). * They will be able to walk without the use of an assistive device * Children can follow instructions and understand given orders. Exclusion Criteria: * Severe visual or hearing impairment. * Fixed deformities or surgical interventions in the lower extremities. * Botulinum toxin injections in the last 6 months.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07683624). StuddyBuddy aggregates publicly available trial information.